Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Communication Key In Receiving PMDA Approval, Accreditation

Devicemakers seeking marketing approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) should facilitate communication with the agency’s inspectors through a close understanding of Japanese quality management system (QMS) rules, preparatory translation of key documents and a skilled interpreter.

A QMS compliance inspection conducted by the PMDA is the most important step in gaining product registration in Japan, David Dills, a regulatory and compliance consultant, said during a recent FDAnews webinar.

The PMDA was established and came into service on April 1, 2004, under the Law for the Pharmaceuticals and Medical Devices Agency, as a consolidation of the services of the Pharmaceuticals and Medical Devices Evaluation Center of the National Institute of Health Sciences (PMDEC), the Organization for Pharmaceutical Safety and Research (OPSR/KIKO), and part of the Japan Association for the Advancement of Medical Equipment (JAAME).